Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-syringe vs. Double-syringe Adenosine for SVT
NCT07554170Phase 4Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- May 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of adenosine in supraventricular tachycardia (SVT), sponsored by Hormozgan University of Medical Sciences. Started May 2024; status: completed.
02
Drugs
adenosine
03
Conditions
supraventricular tachycardia (SVT)
Beyond the preview
Go deeper on NCT07554170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07554170.